Right now, Rupert Hargreaves from The Motley Fool UK is analyzing some of the most popular companies in the FTSE 100 to establish if they are attractive long-term buy and forget investments.
What is the sustainable competitive advantage?
Today I'm looking at National Grid (NG/:LN) (NYSE:NGG). National Grid owns and controls the electricity distribution network for the United Kingdom.
Indeed, apart from some Scottish regions, which are under the control of (LSS:SSE), National Grid has a virtual monopoly over the market.
In addition, as National Grid has been around in various forms since 1926, accumulating over 拢50 billion in assets, a vast and complex distribution network, as well as regulatory approval to run the network, the company has a wide moat defending its position from competitors.
However, the company's US operations, which are only regional networks and account for 35% of EBITDA, are having a hard time fighting off competition.
Hot Information Technology Stocks For 2015: K&S AG (KPLUY.PK)
K&S AG is a Germany-based holding company which is active in the chemical sector. The Company divides its activities into four main business segments. The Potash and Magnesium Products segment is engaged in the crude potash and magnesium salts extraction and in processing raw materials into products for industrial, pharmaceutical, cosmetics and food industries. The Nitrogen Fertilizers business segment distributes fertilizers for almost all agricultural crops, and products for home and garden, plant care and plant protection, specialty fertilizers for public green areas, tree nurseries, horticulture and various special crops are offered. The Salt segment offers food grade salt, industrial salt and salt for chemical use, as well as de-icing salt applied to ensure road safety. The Complementary Business segments include recycling activities and the disposal and reutilization of waste salt mines, granulation of CATASAN, logistics, and trading in different basic chemicals. Advisors' Opinion:- [By Chris Damas]
Other players, such as K+S (KPLUY.PK), Israel Chemicals and APC, Belaruskali and Soquimich (SQM) maintained their world shares at Uralkali's expense.
Top Healthcare Equipment Stocks To Buy For 2014: iShares MSCI France ETF (EWQ)
iShares MSCI France Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the French market, as measured by the MSCI France Index (the Index). The Index seeks to measure the performance of the French equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Jeff Reeves]
So how can you play this trend? The iShares MSCI France ETF (EWQ) is one way, via a diversified fund that owns some of the biggest names in France. There�� also oil giant Total (TOT), which is headquartered in France but has a global flavor, as well as French healthcare giant Sanofi (SNY)
- [By Tom Aspray]
A few weeks ago, I focused on some of the euro countries' debt levels, as well as the improvement in some of their manufacturing data. Their stock markets have continued to rally sharply as the iShares MSCI France (EWQ) is up over 13% since early July and is doing just slightly better than Germany (EWG).
Top Healthcare Equipment Stocks To Buy For 2014: Corcept Therapeutics Incorporated(CORT)
Corcept Therapeutics Incorporated, a development stage pharmaceutical company, engages in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders. The company focuses on the development of drugs for disorders that are associated with steroid hormone called cortisol. Corcept Therapeutics Incorporated has completed its Phase III study of CORLUX for the treatment of Cushing's Syndrome, as well as has an ongoing Phase III study of CORLUX for the treatment of the psychotic features of psychotic depression; and a Phase II program for CORT 108297 and an IND-enabling program for CORT 113083. It has a patent license from Stanford University for the use of GR-II antagonists, as well as agreements with ICON Clinical Research, LP; and MedAvante, Inc. The company was founded in 1998 and is based in Menlo Park, California.
Advisors' Opinion:- [By James E. Brumley]
Looks out Synta Pharmaceuticals Corp. (NASDAQ:SNTA), and AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), you're on notice too. Corcept Therapeutics Incorporated (NASDAQ:CORT) is nipping at your heels, and better still, shares of the company looks like they're about to dole out a sizeable reward to investors who see the writing on the wall.
Top Healthcare Equipment Stocks To Buy For 2014: West Marine Inc (WMAR)
West Marine, Inc., incorporated in September 1993, is a specialty retailer of boating supplies and accessories. The Company offers an assortment of merchandise for the boat and for the boater. It operates in three segments: Stores, Port Supply and Direct-to-Customer. The Company sells to both retail and wholesale customers in its Stores segment. In addition, the Company has three franchised stores in Turkey. The Company�� Port Supply segment is its wholesale segment. The Company�� Direct-to-Customer, which includes e-commerce, catalog and call center transactions. During the year ended December 31, 2011, Stores segment generated approximately 90% of its net revenues. During 2011, products shipped to Port Supply customers directly from its warehouses represented approximately 4% of its net revenues.
During 2011, its Direct Sales segment offered customers around the world more than 75,000 products and accounted for the remaining 6% of its net revenues. Private label products, which the Company sells under the West Marine, Black Tip, Third Reef, Pure Oceans, Lifesling, SeaVolt and Seafit brand names, usually are manufactured in Asia, the United States and Europe.
Stores Segment
During 2011, the Company opened six stores while closing 14 stores. In December 2011, it opened its Fort Lauderdale Boating Superstore, a 50,000 square foot flagship. Its flagship stores ranging in size from 21,000 to 50,000 square feet, offering an array of merchandise typically about 16,000 items, as well as displays designed to help customers make informed product selections. It also operates large format stores, standard-sized stores and smaller Express stores. Its large format stores range from 13,000 to 19,000 square feet and carry about 11,000 items. The standard-sized stores typically range from 6,000 to 12,000 square feet and carry over 6,000 items. Express stores typically range from 2,500 to 3,000 square feet and carry over 4,000 items, mainly hardware and other supplies needed! for day-to-day boat maintenance and repairs.
Port Supply Segment
Port Supply customers include businesses involved in boat sales, boat building, boat commissioning and repair, yacht chartering, marina operations and other boating-related activities. In addition, Port Supply sells to government and industrial customers who use its products for boating and non-boating purposes. Port Supply, the Company�� wholesale segment, serves wholesale customers seeking convenience and a larger assortment of products than those carried by typical distributors.
Direct-to-Customer Segment
The Company�� e-commerce Website provides its customers with access to a selection of approximately 75,000 products, product advisor tips and technical information, over 450 product videos and customer-submitted product reviews. This segment also provides customers with access to knowledgeable technical advisors who can assist its customers in understanding the various uses and applications of the products it sell. It operates a virtual call center from which its associates assist its customers by taking calls from their homes or from its support center in Watsonville, California. Its virtual call center supports sales generated through its e-commerce Website, catalogs and stores and provides customer service offerings.
Advisors' Opinion:- [By Interactive Buyside]
West Marine (Nasdaq: WMAR) is an undervalued retailer. The company is going through a change in focus from a bricks and mortar boat product retailer to a fully integrated retail and wholesale business through bricks and clicks, targeting the boating and water enthusiast customer. Recent results have been affected by a severe rainy and cool spring which hurt boat usage and delayed the start of the season. The company has accelerated cash investments to build larger more productive stores and expand its ecommerce abilities, consequently affecting free cash flow short term. The stock lacks sponsorship as there is only one research report written on the company by a small boutique firm. The stock trades at only book value despite the company being the leading industry player with a solid balance sheet and significant net cash position.
Top Healthcare Equipment Stocks To Buy For 2014: Vanguard Growth Index Fund (VUG)
Vanguard Growth ETF (the Fund), formerly known as Vanguard Growth VIPERs, is an exchange-traded share class of Vanguard Growth Index Fund. The Fund seeks to track the investment performance of the Morgan Stanley Capital International (MSCI) US Prime Market Growth Index (the Index). The Index is designed to represent the large-cap growth segment of the United States equity market.
The Index represents the growth companies of the MSCI US Prime Market 750 Index. The MSCI US Prime Market 750 Index represents the universe of predominantly large-capitalization companies in the United States equity market. The Fund employs a passively managed, full-replication strategy in seeking to track the Index. The Fund invests in all of the Index stocks, holding each stock in approximately the same proportion as its weighting in the Index.
Advisors' Opinion:- [By Mark Salzinger]
Our preferred large-cap growth ETF is Vanguard Growth (VUG), which we feature in all four of our core Best Buys model portfolios. It has fairly broad coverage of growth stocks, with more than 350 holdings. Its expense ratio is a miniscule 0.10%.
- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some growth stocks to your portfolio but don't have the time or expertise to hand-pick a few, the Vanguard Growth ETF (NYSEMKT: VUG ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The Vanguard ETF's expense ratio -- its annual fee -- is a very low 0.10%.
This ETF aspires to beat the S&P 500 soundly, but over the past three and five years, it has slightly underperformed and outperformed it, respectively. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.
Top Healthcare Equipment Stocks To Buy For 2014: Warner Chilcott plc(WCRX)
Warner Chilcott Public Limited Company, a specialty pharmaceutical company, together with its subsidiaries, engages in the development, manufacture, and promotion of branded pharmaceutical products focusing on the women?s healthcare, gastroenterology, dermatology, and urology markets in North America and western Europe. Its principal products include ACTONEL for the prevention and treatment of postmenopausal osteoporosis; ATELVIA for the treatment of postmenopausal osteoporosis; LOESTRIN 24 FE and LO LOESTRIN FE, which are oral contraceptives for the prevention of pregnancy; ESTRACE cream, a vaginal cream for the treatment of vaginal and vulvar atrophy; ASACOL for the treatment of ulcerative colitis for orally administered 5-aminosalicylic acid products and maintenance of remission; ASACOL HD for the treatment of moderately active ulcerative colitis; DORYX, a tetracycline-class oral antibiotic for the treatment of severe acne; and ENABLEX for the treatment of overactive b ladder. The company markets its products and services through wholesale pharmaceutical distributors, and retail drug store chains. It has a strategic collaboration agreement with Sanofi-Aventis U.S. LLC. Warner Chilcott Public Limited Company was founded in 1968 and is headquartered in Dublin, Ireland.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Warner Chilcott (NASDAQ: WCRX ) , a branded pharmaceutical company focused on women's health care, shot higher by as much as 20% after the company reported its first-quarter earnings results, and on news that it could be a buyout target.
- [By Rich Smith]
On Friday, shares of branded pharmaceutical manufacturer Warner Chilcott (NASDAQ: WCRX ) jumped 20% in response to rumors that the company was in talks to sell itself to larger rival Actavis (NYSE: ACT ) . Warner also reported steady earnings, where a decline had been expected, and reiterated full-year guidance.
No comments:
Post a Comment